These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24727009)

  • 1. Removal of acidic pharmaceuticals within a nitrifying recirculating biofilter.
    Krkošek WH; Payne SJ; Gagnon GA
    J Hazard Mater; 2014 May; 273():85-93. PubMed ID: 24727009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selected pharmaceutically active compounds on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations.
    Wang S; Gunsch CK
    Water Res; 2011 May; 45(11):3398-406. PubMed ID: 21529885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of pharmaceutically active compounds in nitrifying-denitrifying plants.
    Suárez S; Ramil M; Omil F; Lema JM
    Water Sci Technol; 2005; 52(8):9-14. PubMed ID: 16312946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradation of ibuprofen, diclofenac and carbamazepine in nitrifying activated sludge under 12 °C temperature conditions.
    Kruglova A; Ahlgren P; Korhonen N; Rantanen P; Mikola A; Vahala R
    Sci Total Environ; 2014 Nov; 499():394-401. PubMed ID: 25215408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspended biofilm carrier and activated sludge removal of acidic pharmaceuticals.
    Falås P; Baillon-Dhumez A; Andersen HR; Ledin A; la Cour Jansen J
    Water Res; 2012 Mar; 46(4):1167-75. PubMed ID: 22209263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor.
    Quintana JB; Weiss S; Reemtsma T
    Water Res; 2005 Jul; 39(12):2654-64. PubMed ID: 15979124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological removal of pharmaceuticals and personal care products during laboratory soil aquifer treatment simulation with different primary substrate concentrations.
    Onesios KM; Bouwer EJ
    Water Res; 2012 May; 46(7):2365-75. PubMed ID: 22374299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of pharmaceuticals under nitrification, nitratation and heterotrophic conditions.
    Fernandez-Fontaina E; Gomes IB; Aga DS; Omil F; Lema JM; Carballa M
    Sci Total Environ; 2016 Jan; 541():1439-1447. PubMed ID: 26479917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment.
    Paxéus N
    Water Sci Technol; 2004; 50(5):253-60. PubMed ID: 15497855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced pharmaceutical removal from water in a three step bio-ozone-bio process.
    de Wilt A; van Gijn K; Verhoek T; Vergnes A; Hoek M; Rijnaarts H; Langenhoff A
    Water Res; 2018 Jul; 138():97-105. PubMed ID: 29574201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate and distribution of pharmaceutically active compounds in mesocosm constructed wetlands.
    He Y; Sutton NB; Lei Y; Rijnaarts HHM; Langenhoff AAM
    J Hazard Mater; 2018 Sep; 357():198-206. PubMed ID: 29886365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selected pharmaceutically active compounds on the ammonia oxidizing bacterium Nitrosomonas europaea.
    Wang S; Gunsch CK
    Chemosphere; 2011 Jan; 82(4):565-72. PubMed ID: 20980043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of pharmaceuticals in full-scale source separated sanitation system.
    Butkovskyi A; Hernandez Leal L; Rijnaarts HH; Zeeman G
    Water Res; 2015 Nov; 85():384-92. PubMed ID: 26364222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
    Ying GG; Kookana RS; Kolpin DW
    J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of solid retention time and nitrification capacity on the ability of activated sludge to remove pharmaceuticals.
    Falås P; Andersen HR; Ledin A; Jansen Jl
    Environ Technol; 2012; 33(7-9):865-72. PubMed ID: 22720411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capacity of a horizontal subsurface flow constructed wetland system for the removal of emerging pollutants: an injection experiment.
    Avila C; Pedescoll A; Matamoros V; Bayona JM; García J
    Chemosphere; 2010 Nov; 81(9):1137-42. PubMed ID: 20864142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies.
    Maeng SK; Sharma SK; Abel CD; Magic-Knezev A; Amy GL
    Water Res; 2011 Oct; 45(16):4722-36. PubMed ID: 21802106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soils.
    Lin K; Gan J
    Chemosphere; 2011 Apr; 83(3):240-6. PubMed ID: 21247615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of selected pharmaceuticals by chlorination, coagulation-sedimentation and powdered activated carbon treatment.
    Simazaki D; Fujiwara J; Manabe S; Matsuda M; Asami M; Kunikane S
    Water Sci Technol; 2008; 58(5):1129-35. PubMed ID: 18824814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.